Report overview
The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer.
This report contains market size and forecasts of Prophylactic Hepatitis B Virus Vaccines in Global, including the following market information:
Global Prophylactic Hepatitis B Virus Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prophylactic Hepatitis B Virus Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hepatitis B Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prophylactic Hepatitis B Virus Vaccines include Merck, Sanofi Pasteur, Novartis, Pfizer and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prophylactic Hepatitis B Virus Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prophylactic Hepatitis B Virus Vaccines Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prophylactic Hepatitis B Virus Vaccines Market Segment Percentages, by Type, 2021 (%)
Hepatitis B
Liver Cirrhosis
Hepatocellular Carcinoma
Liver Failure
Global Prophylactic Hepatitis B Virus Vaccines Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Prophylactic Hepatitis B Virus Vaccines Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Global Prophylactic Hepatitis B Virus Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Prophylactic Hepatitis B Virus Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prophylactic Hepatitis B Virus Vaccines revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prophylactic Hepatitis B Virus Vaccines revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Sanofi Pasteur
Novartis
Pfizer
GlaxoSmithKline
